AG真人官方

Cameron Wheeler, Director at Nuvalent (NUVL), reported two significant equity transactions on June 18, 2025:

• Acquired 2,647 Restricted Stock Units (RSUs) at $0.00, convertible to Class A Common Stock. These RSUs vest fully on June 18, 2026, or at the next annual stockholder meeting
• Received stock options to purchase 4,147 shares at an exercise price of $75.53 per share, expiring June 18, 2035

Important disclosure: Wheeler, a partner at Deerfield Management Company, L.P., holds these securities for the benefit of Deerfield Management and disclaims beneficial ownership. Following these transactions, Wheeler directly owns 5,146 shares and 4,147 stock options. Both the RSUs and options are subject to continued service requirements.

Director Sapna Srivastava of Nuvalent received new equity compensation on June 18, 2025, consisting of:

• 2,647 Restricted Stock Units (RSUs) convertible to Class A Common Stock at $0.00, bringing total direct RSU ownership to 5,146 shares
• 4,147 Stock Options with strike price of $75.53, exercisable until June 18, 2035

Both the RSUs and stock options vest in full on the earlier of June 18, 2026 or the next annual stockholder meeting, contingent on continued service. This grant appears to be part of the company's director compensation program. The filing was submitted through an attorney-in-fact on June 20, 2025.

Nuvalent Director Matthew Shair reported multiple securities transactions on June 18, 2025. The transactions include:

• Acquisition of 2,647 restricted stock units (RSUs) at $0.00, convertible to Class A Common Stock. These RSUs vest fully by June 18, 2026 or the next annual stockholder meeting
• Grant of stock options to purchase 4,147 shares at $75.53 per share, expiring June 18, 2035

Following these transactions, Shair directly owns 1,429,844 shares of Class A Common Stock and indirectly controls 216,522 shares through the Matthew D. Shair 2021 Irrevocable Family Trust. The compensation package appears to be part of standard director remuneration, with both RSUs and options subject to one-year vesting periods tied to continued service.

Nuvalent director Anna Protopapas received new equity compensation grants on June 18, 2025, consisting of:

• 2,647 Restricted Stock Units (RSUs) of Class A Common Stock at $0.00, which vest in full on the earlier of June 18, 2026, or the next annual stockholder meeting
• 4,147 Stock Options with a strike price of $75.53, exercisable until June 18, 2035, following the same vesting schedule as the RSUs

Following these transactions, Protopapas directly owns 5,146 shares of Class A Common Stock and 4,147 stock options. These grants appear to be part of the company's director compensation program, with a one-year vesting period tied to continued service on the board.

Joseph Pearlberg, Director at Nuvalent (NUVL), reported two significant equity transactions on June 18, 2025:

• Acquired 2,647 Restricted Stock Units (RSUs) at $0.00, convertible to Class A Common Stock. These RSUs will fully vest on June 18, 2026, or at the next annual stockholder meeting, bringing total direct ownership to 5,146 shares
• Received stock options to purchase 4,147 shares at an exercise price of $75.53, expiring June 18, 2035. Options follow the same vesting schedule as the RSUs

Important disclosure: Pearlberg, an employee of Deerfield Management Company, holds these securities for Deerfield's benefit and direction, disclaiming personal beneficial ownership. This suggests an institutional relationship between Deerfield Management and Nuvalent's governance structure.

Nuvalent, Inc. (NUVL) filed a Form 4 disclosing routine director equity compensation. Director Michael L. Meyers reported transactions dated 18 June 2025.

• Restricted Stock Units (RSUs): 2,647 Class A shares awarded at no cost. RSUs vest in full on the earlier of 18 June 2026 or the company鈥檚 next annual shareholders鈥� meeting, contingent on continued service.
• Stock Options: 4,147 options granted with a US$75.53 exercise price and 18 June 2035 expiry. The entire option grant vests on the same schedule as the RSUs.
• Post-transaction ownership: Meyers now directly holds 5,146 Class A shares. All newly reported securities were granted, not purchased on the open market.

The filing reflects standard annual board compensation rather than an open-market purchase or sale. As such, the event is generally viewed as neutral to Nuvalent鈥檚 valuation, though the additional insider ownership modestly aligns director and shareholder interests.

Nuvalent, Inc. (NASDAQ: NUVL) 鈥� Form 4 filing dated 20 Jun 2025

Director Grant C. Bogle reported the receipt of two equity awards on 18 Jun 2025:

• 2,647 restricted stock units (RSUs) representing Class A common shares. The RSUs were awarded at no cash cost and will vest in full on the earlier of 18 Jun 2026 or the company鈥檚 next annual meeting, conditional on continued board service.
• 4,147 stock options with an exercise price of $75.53, also vesting on the same schedule and expiring on 18 Jun 2035.

Following the grant, Bogle鈥檚 direct beneficial ownership stands at 5,847 Class A shares and 4,147 vested/unvested options. The transaction was coded 鈥淎鈥� (award) and involved no open-market purchase or sale of shares, indicating routine, board-approved compensation rather than an insider-driven valuation signal.

The share amounts involved are modest relative to Nuvalent鈥檚 public float; therefore, any dilution effect is immaterial. No changes to corporate strategy, earnings outlook, or insider sentiment beyond standard compensation practices are implied by this filing.

Nuvalent, Inc. (NUVL) filed a Form 4 disclosing that director Christy J. Oliger received new equity awards on 18 June 2025.

• 3,971 Restricted Stock Units (RSUs): Granted at no cost. The RSUs convert to an equal number of Class A shares in three equal annual installments beginning one year from the grant date, provided the director remains in service.
• 6,119 Stock Options: Right to buy Class A shares at an exercise price of $75.53, expiring 18 June 2035. Vesting occurs monthly over the three-year period following the grant.

Post-grant, Oliger directly owns 3,971 Class A shares and holds derivative rights (options) to acquire an additional 6,119 shares. The filing reports no sales or dispositions.

These awards form part of Nuvalent鈥檚 standard director compensation package, creating long-term alignment with shareholder interests through multi-year vesting schedules. Because the transactions are grants rather than market purchases or sales, they do not immediately affect cash flow or trading volume but do incrementally increase potential dilution if options are exercised in the future.

Form 3 Overview: Nuvalent, Inc. (NUVL) filed an Initial Statement of Beneficial Ownership for Ms. Christy J. Oliger on 06/20/2025, reporting an event date of 06/18/2025.

Key Details:

• Reporting Person: Christy J. Oliger
• Relationship to Issuer: Director (no other roles indicated)
• Beneficial Ownership: The filer explicitly states 鈥淣o securities are beneficially owned.鈥�
• Filing Type: Form filed by one reporting person; accompanied by a Power of Attorney (Exhibit 24) signed by attorney-in-fact Nathan N. McConarty.

Investor Takeaway: A Form 3 signals an insider鈥檚 entry into the company鈥檚 reporting framework. However, because the form shows zero shares owned, there is no immediate dilution, concentration change, or valuation signal. The filing is largely administrative, confirming Ms. Oliger鈥檚 board position and future reporting obligations under Section 16(a).